Finance

Beta
Lists
9966:HKG
Alphamab Oncology
HK$7.20
+8.43%
(+0.56) 1D
Jun 11, 4:08:28 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 9966...
Open
HK$6.83
High
HK$7.20
Low
HK$6.80
Mkt. cap
6.97B
Avg. vol.
1.99M
Volume
3.75M
52-wk high
HK$15.75
52-wk low
HK$6.01
EPS
-HK$0.14
No. of employees
498
Open
HK$6.83
High
HK$7.20
Low
HK$6.80
Mkt. cap
6.97B
Avg. vol.
1.99M
Volume
3.75M
52-wk high
HK$15.75
52-wk low
HK$6.01
EPS
-HK$0.14
No. of employees
498
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to 9966 in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for 9966 in the last 3 months.
Highest
Current HK$7.20
HK$9.60 (+33.33%)
Average
HK$9.60 (+33.33%)
Lowest
HK$9.60 (+33.33%)
News stories
From sources across the web
About Alphamab Oncology
CEOTing Xu
Employees498
Founded2008
Headquarters-
SectorBiotechnology
Websitealphamabonc.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
159.72M
159.72M
123.40M
123.40M
Cost of goods sold
15.63M
15.63M
16.14M
16.14M
Cost of revenue
15.63M
15.63M
16.14M
16.14M
Research and development expenses
126.47M
126.47M
159.43M
159.43M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.30M
17.30M
24.79M
24.79M
Operating expense
143.77M
143.77M
184.22M
184.22M
Total operating expenses
159.40M
159.40M
200.37M
200.37M
Operating income
321.50K
321.50K
-76.97M
-76.97M
Other non operating income
3.37M
3.37M
5.05M
5.05M
EBT including unusual items
10.79M
10.79M
-67.76M
-67.76M
EBT excluding unusual items
10.79M
10.79M
-67.76M
-67.76M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
10.79M
10.79M
-67.76M
-67.76M
Net profit margin
6.75%
6.75%
-54.91%
-54.91%
Earnings per share
-
-
-
-
Interest and investment income
9.89M
9.89M
7.75M
7.75M
Interest expense
-1.97M
-1.97M
-1.75M
-1.75M
Net interest expenses
7.92M
7.92M
6.00M
6.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
15.42M
15.42M
-61.19M
-61.19M
Gain or loss from assets sale
340.50K
340.50K
1.00K
1.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer